References
- Bode, G., Clausing, P., Gervais, F., et al. (2010). The utility of the minipig as an animal model in regulatory toxicology. J. Pharmacol. Toxicol. Meth. 62:196–220
- Gad, S. C., Dincer, Z., Svendsen, O., and Skaanild, M. T. (2007). The minipig. In: Animal Models in Toxicology, 2nd ed. (Gad, S. C., Ed.). Boca Raton, FL: CRC Press, pp. 731–771
- Hinton, D. M., and Khan, M. A. (1989). Evaluation of the miniature swine for use in immunotoxicity assessment: I. Quantitation of humoral responses to sheep red blood cells and effects of cyclophosphamide. J. Am. Coll. Toxicol. 8:1039–1052
- ICH. (2005). S8 Immunotoxicity Studies for Human Pharmaceuticals. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available online at: http://www.ich.org/products/guidelines/safety/safety-single/article/immunotoxicity-studies-for-human-pharmaceuticals.html
- Joling, P., Mok, K. S., de Vries Reilingh, V., et al. (1993). An evaluation of immune competence in different swine breeds. Vet. Quart. 15:9–15
- Köhn, F. (2012). History and development of miniature, micro- and minipigs. In: The Minipig in Biomedical Research. (McAnulty, P. A., Dayan, A. D., Ganderup, N., and Hastings, K. L.). Boca Raton, FL: CRC Press, pp. 3–15
- Köhn, F., Sharifi, A. R., and Simianer, H. (2007). Modeling the growth of the Gottingen minipig. J. Anim. Sci. 85:84–92
- Luster, M. I., Portier, C., Pait, D. G., et al. (1992). Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200–210
- Mackie, E. J. (1981). Immunosuppressive effects of cyclophosphamide in pigs. Am. J. Vet. Res. 42:189–194
- Penninks, A. H., and van Mierlo, G. J. (2012). Immunotoxicology studies in the minipig. In: The Minipig in Biomedical Research. (McAnulty, P. A., Dayan, A. D., Ganderup, N., and Hastings, K. L.). Boca Raton, FL: CRC Press, pp. 397–411
- Rothkötter, H. J. (2009). Anatomical and particularities of the porcine immune system - a physician's view. Dev. Comp. Immunol. 33:267–272
- Svendsen, O. (2006). The minipig in toxicology. Exp. Toxicol. Pathol. 57:335–339
- Svendsen, O., Skydsgaard, M., Aarup, V., and Klastrup, S. (1998). Spontaneously occurring microscopic lesions in selected organs of the Göttingen minipig. Scand. J. Lab. Anim. Sci. 25:231–234
- Swindle, M. M., and Smith, A. C. (1998). Comparative anatomy and physiology of the pig. Scand. J. Lab. Anim. Sci. 25:11–21
- Thalhammer, J. G., Stockl, W., and Reyero, C. (1978). Effects of the B-cell activators lipid A and dextran sulphate on the antibody response to sheep red blood cells in piglets. Immunology 35:793–799
- USFDA (US Food and Drug Administration). (2006). S8 Immunotoxicity Studies for Human Pharmaceuticals. Washington, DC: U.S. Department of Health and Human Services
- van der Laan, J. W., Brightwell, J., McAnulty, P. A., et al. (2010). Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products. J. Pharmacol. Toxicol. Meth. 62:184–195
- Yang, H., and Parkhouse, R. M. (1996). Phenotypic classification of porcine lymphocyte sub-populations in blood and lymphoid tissues. Immunology 89:76–83